| 0 |
NPM1 GENE MUTATION |
11 |
0.7857 |
| 1 |
PSEUDOALDOSTERONISM |
97 |
0.4899 |
| 2 |
PROTOTHECOSIS |
34 |
0.3617 |
| 3 |
ANTIBIOTIC LEVEL BELOW THERAPEUTIC |
29 |
0.2843 |
| 4 |
ACQUIRED APPARENT MINERALOCORTICOID EXCESS |
17 |
0.2742 |
| 5 |
LEFT ATRIAL HYPERTROPHY |
11 |
0.2200 |
| 6 |
DEMODICIDOSIS |
19 |
0.2065 |
| 7 |
FUSARIUM INFECTION |
118 |
0.1686 |
| 8 |
MICROSPORIDIA INFECTION |
50 |
0.1425 |
| 9 |
ADENOVIRUS REACTIVATION |
20 |
0.1389 |
| 10 |
APPARENT MINERALOCORTICOID EXCESS |
8 |
0.1379 |
| 11 |
GEOTRICHUM INFECTION |
29 |
0.1374 |
| 12 |
CHIMERISM |
11 |
0.1236 |
| 13 |
ACANTHAMOEBA INFECTION |
23 |
0.1223 |
| 14 |
CEREBRAL VENTRICLE COLLAPSE |
9 |
0.1200 |
| 15 |
CORYNEBACTERIUM BACTERAEMIA |
10 |
0.1176 |
| 16 |
SCEDOSPORIUM INFECTION |
83 |
0.1176 |
| 17 |
ENCEPHALITIS FUNGAL |
10 |
0.1111 |
| 18 |
DISSEMINATED TOXOPLASMOSIS |
13 |
0.1083 |
| 19 |
ALLOGENIC STEM CELL TRANSPLANTATION |
17 |
0.1076 |
| 20 |
BRONCHIOLITIS OBLITERANS SYNDROME |
18 |
0.1029 |
| 21 |
BK POLYOMAVIRUS TEST POSITIVE |
9 |
0.0938 |
| 22 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
16 |
0.0925 |
| 23 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
21 |
0.0905 |
| 24 |
DIFFERENTIATION SYNDROME |
65 |
0.0886 |
| 25 |
HEPATOSPLENIC CANDIDIASIS |
13 |
0.0884 |
| 26 |
OVERGROWTH FUNGAL |
9 |
0.0874 |
| 27 |
PULMONARY MUCORMYCOSIS |
43 |
0.0814 |
| 28 |
ENTEROBACTER BACTERAEMIA |
24 |
0.0792 |
| 29 |
DISSEMINATED COCCIDIOIDOMYCOSIS |
11 |
0.0780 |
| 30 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
164 |
0.0763 |
| 31 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
13 |
0.0756 |
| 32 |
PRIMARY ADRENAL INSUFFICIENCY |
23 |
0.0754 |
| 33 |
EYE INFECTION FUNGAL |
28 |
0.0724 |
| 34 |
ADENOVIRAL HEPATITIS |
17 |
0.0723 |
| 35 |
MUCORMYCOSIS |
187 |
0.0719 |
| 36 |
GRAFT VERSUS HOST DISEASE IN INTESTINE |
9 |
0.0692 |
| 37 |
RHINOCEREBRAL MUCORMYCOSIS |
23 |
0.0663 |
| 38 |
LIP SQUAMOUS CELL CARCINOMA |
11 |
0.0655 |
| 39 |
MYCETOMA MYCOTIC |
9 |
0.0647 |
| 40 |
PHAEOHYPHOMYCOSIS |
31 |
0.0647 |
| 41 |
SYSTEMIC MYCOSIS |
75 |
0.0642 |
| 42 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
92 |
0.0635 |
| 43 |
MYCOTIC ENDOPHTHALMITIS |
12 |
0.0635 |
| 44 |
CEREBRAL ASPERGILLOSIS |
39 |
0.0634 |
| 45 |
CUTANEOUS MUCORMYCOSIS |
11 |
0.0598 |
| 46 |
CHRONIC GRAFT VERSUS HOST DISEASE IN EYE |
12 |
0.0591 |
| 47 |
ELECTROCARDIOGRAM PR SHORTENED |
12 |
0.0571 |
| 48 |
ABSCESS FUNGAL |
10 |
0.0571 |
| 49 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
22 |
0.0566 |
| 50 |
CONGENITAL APLASIA |
17 |
0.0547 |
| 51 |
GRAFT VERSUS HOST DISEASE IN LUNG |
26 |
0.0544 |
| 52 |
GASTROINTESTINAL MUCORMYCOSIS |
9 |
0.0539 |
| 53 |
NEUTROPHIL PELGER-HUET ANOMALY PRESENT |
10 |
0.0535 |
| 54 |
PNEUMONIA FUNGAL |
199 |
0.0504 |
| 55 |
GRAFT VERSUS HOST DISEASE IN LIVER |
36 |
0.0503 |
| 56 |
ANTICOAGULATION DRUG LEVEL INCREASED |
16 |
0.0498 |
| 57 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
106 |
0.0498 |
| 58 |
CYSTITIS VIRAL |
19 |
0.0496 |
| 59 |
ENTEROBACTER TEST POSITIVE |
12 |
0.0488 |
| 60 |
ZYGOMYCOSIS |
22 |
0.0470 |
| 61 |
HERPES SIMPLEX REACTIVATION |
17 |
0.0446 |
| 62 |
GRAFT VERSUS HOST DISEASE IN SKIN |
96 |
0.0435 |
| 63 |
DISSEMINATED MUCORMYCOSIS |
17 |
0.0431 |
| 64 |
ASPERGILLUS TEST POSITIVE |
13 |
0.0422 |
| 65 |
SYSTEMIC CANDIDA |
105 |
0.0418 |
| 66 |
INTRAOCULAR PRESSURE TEST |
10 |
0.0417 |
| 67 |
FUNGAEMIA |
62 |
0.0394 |
| 68 |
ASPERGILLUS INFECTION |
255 |
0.0388 |
| 69 |
ECTHYMA |
15 |
0.0374 |
| 70 |
SINUSITIS FUNGAL |
30 |
0.0374 |
| 71 |
GRAFT VERSUS HOST DISEASE |
265 |
0.0368 |
| 72 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
52 |
0.0368 |
| 73 |
GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION |
10 |
0.0368 |
| 74 |
CEREBRAL TOXOPLASMOSIS |
34 |
0.0364 |
| 75 |
SEPTIC EMBOLUS |
30 |
0.0361 |
| 76 |
KLEBSIELLA BACTERAEMIA |
34 |
0.0358 |
| 77 |
ENTEROCOCCAL BACTERAEMIA |
37 |
0.0349 |
| 78 |
UREAPLASMA INFECTION |
14 |
0.0343 |
| 79 |
GRAFT COMPLICATION |
20 |
0.0341 |
| 80 |
VIRAL HAEMORRHAGIC CYSTITIS |
24 |
0.0337 |
| 81 |
BRONCHOPULMONARY ASPERGILLOSIS |
256 |
0.0330 |
| 82 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
145 |
0.0328 |
| 83 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
23 |
0.0320 |
| 84 |
GROWTH FAILURE |
11 |
0.0320 |
| 85 |
RESPIRATORY TRACT INFECTION FUNGAL |
16 |
0.0303 |
| 86 |
IDIOPATHIC PNEUMONIA SYNDROME |
9 |
0.0302 |
| 87 |
VENOUS HAEMORRHAGE |
9 |
0.0290 |
| 88 |
PARAINFLUENZAE VIRUS INFECTION |
44 |
0.0289 |
| 89 |
TRANSPLANTATION COMPLICATION |
12 |
0.0286 |
| 90 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
79 |
0.0286 |
| 91 |
CHRONIC GRAFT VERSUS HOST DISEASE |
102 |
0.0282 |
| 92 |
CITROBACTER INFECTION |
12 |
0.0280 |
| 93 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
10 |
0.0275 |
| 94 |
CHOROIDAL EFFUSION |
22 |
0.0274 |
| 95 |
ENTEROBACTER SEPSIS |
10 |
0.0270 |
| 96 |
CARDIAC VALVE VEGETATION |
13 |
0.0267 |
| 97 |
NEUTROPENIC INFECTION |
25 |
0.0261 |
| 98 |
HYPERLEUKOCYTOSIS |
23 |
0.0260 |
| 99 |
KLEBSIELLA SEPSIS |
29 |
0.0257 |
| 100 |
SINOATRIAL BLOCK |
15 |
0.0252 |
| 101 |
NECROTISING RETINITIS |
16 |
0.0250 |
| 102 |
BK VIRUS INFECTION |
81 |
0.0240 |
| 103 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
22 |
0.0238 |
| 104 |
GLUCOCORTICOID DEFICIENCY |
10 |
0.0236 |
| 105 |
STENOTROPHOMONAS INFECTION |
32 |
0.0236 |
| 106 |
PSEUDOMONAL BACTERAEMIA |
20 |
0.0234 |
| 107 |
PLATELET TRANSFUSION |
30 |
0.0233 |
| 108 |
RETINAL ISCHAEMIA |
14 |
0.0229 |
| 109 |
CARDIOACTIVE DRUG LEVEL INCREASED |
30 |
0.0228 |
| 110 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
14 |
0.0213 |
| 111 |
BRAIN ABSCESS |
54 |
0.0213 |
| 112 |
LUNG TRANSPLANT REJECTION |
14 |
0.0212 |
| 113 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
69 |
0.0209 |
| 114 |
ESCHERICHIA BACTERAEMIA |
49 |
0.0208 |
| 115 |
LEUKAEMIA RECURRENT |
35 |
0.0207 |
| 116 |
ASPERGILLOSIS |
27 |
0.0207 |
| 117 |
ACUTE MYELOID LEUKAEMIA |
321 |
0.0206 |
| 118 |
MYOPERICARDITIS |
16 |
0.0205 |
| 119 |
NEUTROPENIC COLITIS |
42 |
0.0203 |
| 120 |
ENTEROCOCCAL INFECTION |
98 |
0.0203 |
| 121 |
DRUG LEVEL BELOW THERAPEUTIC |
111 |
0.0201 |
| 122 |
BRAIN COMPRESSION |
8 |
0.0200 |
| 123 |
ENTEROCOCCAL SEPSIS |
16 |
0.0198 |
| 124 |
PULMONARY NOCARDIOSIS |
16 |
0.0194 |
| 125 |
PARTIAL SEIZURES WITH SECONDARY GENERALISATION |
9 |
0.0192 |
| 126 |
POLYMYOSITIS |
34 |
0.0192 |
| 127 |
PSEUDOMONAL SEPSIS |
33 |
0.0188 |
| 128 |
MINIMAL RESIDUAL DISEASE |
9 |
0.0186 |
| 129 |
ENGRAFTMENT SYNDROME |
11 |
0.0186 |
| 130 |
STAPHYLOCOCCAL BACTERAEMIA |
80 |
0.0184 |
| 131 |
COAGULATION TEST ABNORMAL |
14 |
0.0182 |
| 132 |
INFECTIVE ANEURYSM |
9 |
0.0182 |
| 133 |
MYCOBACTERIUM ABSCESSUS INFECTION |
13 |
0.0182 |
| 134 |
ANAEMIA MEGALOBLASTIC |
8 |
0.0179 |
| 135 |
METAPNEUMOVIRUS INFECTION |
14 |
0.0179 |
| 136 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
16 |
0.0173 |
| 137 |
HAEMATOLOGICAL INFECTION |
42 |
0.0172 |
| 138 |
HYPOFIBRINOGENAEMIA |
17 |
0.0171 |
| 139 |
FEBRILE NEUTROPENIA |
1099 |
0.0166 |
| 140 |
SOFT TISSUE INFECTION |
30 |
0.0164 |
| 141 |
APLASIA |
32 |
0.0163 |
| 142 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
21 |
0.0159 |
| 143 |
PULMONARY MYCOSIS |
12 |
0.0154 |
| 144 |
BLAST CELL COUNT INCREASED |
16 |
0.0153 |
| 145 |
INTRACRANIAL MASS |
14 |
0.0148 |
| 146 |
PNEUMONIA KLEBSIELLA |
27 |
0.0147 |
| 147 |
STEROID DIABETES |
22 |
0.0147 |
| 148 |
ADENOVIRUS INFECTION |
42 |
0.0145 |
| 149 |
FUNGAL SEPSIS |
12 |
0.0144 |
| 150 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
85 |
0.0143 |
| 151 |
PNEUMONIA PSEUDOMONAL |
22 |
0.0143 |
| 152 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
11 |
0.0143 |
| 153 |
PSEUDOMONAS INFECTION |
122 |
0.0142 |
| 154 |
BACTERAEMIA |
168 |
0.0141 |
| 155 |
STREPTOCOCCAL BACTERAEMIA |
15 |
0.0138 |
| 156 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
39 |
0.0138 |
| 157 |
BONE MARROW TRANSPLANT |
26 |
0.0137 |
| 158 |
NOCARDIOSIS |
35 |
0.0137 |
| 159 |
COCCIDIOIDOMYCOSIS |
16 |
0.0134 |
| 160 |
SINUSITIS BACTERIAL |
14 |
0.0133 |
| 161 |
HYPERBILIRUBINAEMIA |
137 |
0.0132 |
| 162 |
OESOPHAGITIS ULCERATIVE |
9 |
0.0132 |
| 163 |
INFECTION REACTIVATION |
15 |
0.0131 |
| 164 |
CYTOMEGALOVIRUS VIRAEMIA |
58 |
0.0130 |
| 165 |
NEPHROGENIC DIABETES INSIPIDUS |
15 |
0.0130 |
| 166 |
VENOOCCLUSIVE LIVER DISEASE |
64 |
0.0129 |
| 167 |
STEM CELL TRANSPLANT |
32 |
0.0128 |
| 168 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
10 |
0.0127 |
| 169 |
CEREBRAL ARTERY EMBOLISM |
15 |
0.0123 |
| 170 |
CANDIDA SEPSIS |
11 |
0.0123 |
| 171 |
ACUTE GRAFT VERSUS HOST DISEASE |
56 |
0.0122 |
| 172 |
CYTOPENIA |
149 |
0.0122 |
| 173 |
TUMOUR LYSIS SYNDROME |
107 |
0.0121 |
| 174 |
KLEBSIELLA INFECTION |
61 |
0.0121 |
| 175 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
31 |
0.0120 |
| 176 |
CYSTITIS HAEMORRHAGIC |
48 |
0.0119 |
| 177 |
HEPATIC CYTOLYSIS |
151 |
0.0118 |
| 178 |
BICYTOPENIA |
23 |
0.0117 |
| 179 |
ESCHERICHIA SEPSIS |
34 |
0.0117 |
| 180 |
BLOOD IMMUNOGLOBULIN G DECREASED |
29 |
0.0117 |
| 181 |
AXONAL NEUROPATHY |
10 |
0.0115 |
| 182 |
BACTERIAL SEPSIS |
37 |
0.0113 |
| 183 |
CENTRAL NERVOUS SYSTEM INFECTION |
13 |
0.0113 |
| 184 |
MYOSITIS |
101 |
0.0112 |
| 185 |
PELVIC VENOUS THROMBOSIS |
16 |
0.0112 |
| 186 |
BILIRUBIN CONJUGATED INCREASED |
26 |
0.0111 |
| 187 |
CELL DEATH |
22 |
0.0111 |
| 188 |
HYPOGONADISM |
11 |
0.0109 |
| 189 |
EPSTEIN-BARR VIRAEMIA |
12 |
0.0108 |
| 190 |
RENAL TUBULAR DISORDER |
30 |
0.0107 |
| 191 |
CAPILLARY LEAK SYNDROME |
22 |
0.0106 |
| 192 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
16 |
0.0106 |
| 193 |
SEPTIC SHOCK |
461 |
0.0106 |
| 194 |
ILEUS PARALYTIC |
47 |
0.0105 |
| 195 |
TRANSPLANT |
25 |
0.0105 |
| 196 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
64 |
0.0105 |
| 197 |
BRAIN HERNIATION |
31 |
0.0104 |
| 198 |
STAPHYLOCOCCAL SEPSIS |
51 |
0.0103 |
| 199 |
LUNG OPACITY |
27 |
0.0102 |
| 200 |
CYTOMEGALOVIRUS TEST POSITIVE |
18 |
0.0101 |
| 201 |
RENAL TUBULAR ACIDOSIS |
22 |
0.0101 |
| 202 |
LONG QT SYNDROME |
24 |
0.0100 |
| 203 |
MUSCLE NECROSIS |
9 |
0.0099 |
| 204 |
INFECTIOUS PLEURAL EFFUSION |
15 |
0.0098 |
| 205 |
PATHOGEN RESISTANCE |
89 |
0.0098 |
| 206 |
LUNG CONSOLIDATION |
27 |
0.0096 |
| 207 |
CHOLESTASIS |
185 |
0.0096 |
| 208 |
PULMONARY SEPSIS |
14 |
0.0096 |
| 209 |
ENTEROBACTER INFECTION |
16 |
0.0095 |
| 210 |
ADRENAL SUPPRESSION |
8 |
0.0095 |
| 211 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
71 |
0.0095 |
| 212 |
THROMBOTIC MICROANGIOPATHY |
92 |
0.0094 |
| 213 |
FEBRILE INFECTION |
11 |
0.0093 |
| 214 |
PNEUMONIA CYTOMEGALOVIRAL |
18 |
0.0093 |
| 215 |
CYTOKINE RELEASE SYNDROME |
185 |
0.0092 |
| 216 |
CYTOMEGALOVIRUS INFECTION |
152 |
0.0091 |
| 217 |
LEUKOENCEPHALOPATHY |
34 |
0.0091 |
| 218 |
ENCEPHALITIS VIRAL |
11 |
0.0090 |
| 219 |
FEBRILE BONE MARROW APLASIA |
38 |
0.0089 |
| 220 |
DEVICE RELATED INFECTION |
134 |
0.0087 |
| 221 |
ACUTE LEUKAEMIA |
14 |
0.0087 |
| 222 |
EXTREMITY NECROSIS |
15 |
0.0086 |
| 223 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
26 |
0.0086 |
| 224 |
HEPATIC NECROSIS |
32 |
0.0085 |
| 225 |
BONE MARROW TOXICITY |
10 |
0.0084 |
| 226 |
OBLITERATIVE BRONCHIOLITIS |
11 |
0.0084 |
| 227 |
ATYPICAL PNEUMONIA |
25 |
0.0084 |
| 228 |
ESCHERICHIA TEST POSITIVE |
10 |
0.0083 |
| 229 |
TORSADE DE POINTES |
64 |
0.0081 |
| 230 |
OPTIC NEUROPATHY |
17 |
0.0080 |
| 231 |
HERPES SIMPLEX |
52 |
0.0080 |
| 232 |
RHINOVIRUS INFECTION |
31 |
0.0080 |
| 233 |
DRUG LEVEL DECREASED |
81 |
0.0080 |
| 234 |
HYPOGAMMAGLOBULINAEMIA |
52 |
0.0079 |
| 235 |
JUGULAR VEIN THROMBOSIS |
14 |
0.0079 |
| 236 |
ANGLE CLOSURE GLAUCOMA |
20 |
0.0078 |
| 237 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
221 |
0.0078 |
| 238 |
METHAEMOGLOBINAEMIA |
18 |
0.0078 |
| 239 |
EPSTEIN-BARR VIRUS INFECTION |
48 |
0.0077 |
| 240 |
ENTEROCOLITIS |
44 |
0.0076 |
| 241 |
BONE MARROW DISORDER |
23 |
0.0076 |
| 242 |
DRUG RESISTANCE |
194 |
0.0075 |
| 243 |
NEPHROPATHY TOXIC |
84 |
0.0075 |
| 244 |
PLASMA CELL MYELOMA REFRACTORY |
10 |
0.0075 |
| 245 |
NEUTROPENIC SEPSIS |
53 |
0.0074 |
| 246 |
SKIN NECROSIS |
38 |
0.0073 |
| 247 |
ACINETOBACTER INFECTION |
8 |
0.0073 |
| 248 |
APLASTIC ANAEMIA |
38 |
0.0073 |
| 249 |
PANCYTOPENIA |
402 |
0.0072 |
| 250 |
ACUTE PULMONARY OEDEMA |
40 |
0.0071 |
| 251 |
HYPOMAGNESAEMIA |
99 |
0.0071 |
| 252 |
LEUKAEMIA |
67 |
0.0071 |
| 253 |
FUNGAL INFECTION |
236 |
0.0071 |
| 254 |
PRODUCT DEPOSIT |
11 |
0.0071 |
| 255 |
CANDIDA INFECTION |
119 |
0.0070 |
| 256 |
INHIBITORY DRUG INTERACTION |
11 |
0.0069 |
| 257 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
12 |
0.0069 |
| 258 |
HUMAN HERPESVIRUS 6 INFECTION |
13 |
0.0069 |
| 259 |
HEPATOCELLULAR INJURY |
97 |
0.0068 |
| 260 |
HYPOPHOSPHATAEMIA |
50 |
0.0068 |
| 261 |
HYPOKALAEMIA |
311 |
0.0067 |
| 262 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
64 |
0.0067 |
| 263 |
HOSPICE CARE |
66 |
0.0067 |
| 264 |
BONE MARROW FAILURE |
135 |
0.0066 |
| 265 |
CYTOLYTIC HEPATITIS |
22 |
0.0066 |
| 266 |
GASTRIC DILATATION |
11 |
0.0066 |
| 267 |
DRUG INTERACTION |
1042 |
0.0066 |
| 268 |
HEPATOTOXICITY |
146 |
0.0066 |
| 269 |
ELECTROCARDIOGRAM QT PROLONGED |
235 |
0.0065 |
| 270 |
DEVICE RELATED SEPSIS |
13 |
0.0065 |
| 271 |
VASCULAR PURPURA |
9 |
0.0064 |
| 272 |
GASTROINTESTINAL TOXICITY |
31 |
0.0064 |
| 273 |
NEUROTOXICITY |
113 |
0.0064 |
| 274 |
DRUG LEVEL INCREASED |
105 |
0.0063 |
| 275 |
DRUG LEVEL ABOVE THERAPEUTIC |
29 |
0.0063 |
| 276 |
MIXED LIVER INJURY |
19 |
0.0063 |
| 277 |
FUNGAL SKIN INFECTION |
25 |
0.0062 |
| 278 |
CYTOMEGALOVIRUS COLITIS |
14 |
0.0061 |
| 279 |
HEPATITIS FULMINANT |
18 |
0.0061 |
| 280 |
VENOOCCLUSIVE DISEASE |
15 |
0.0060 |
| 281 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
13 |
0.0059 |
| 282 |
BACTERIAL INFECTION |
110 |
0.0059 |
| 283 |
LUNG INFILTRATION |
52 |
0.0059 |
| 284 |
LUNG ABSCESS |
12 |
0.0057 |
| 285 |
ENDOPHTHALMITIS |
34 |
0.0057 |
| 286 |
NEUTROPENIA |
770 |
0.0057 |
| 287 |
ORGANISING PNEUMONIA |
28 |
0.0056 |
| 288 |
PERIPHERAL SENSORY NEUROPATHY |
33 |
0.0056 |
| 289 |
JC VIRUS INFECTION |
9 |
0.0056 |
| 290 |
STUPOR |
18 |
0.0056 |
| 291 |
DISINHIBITION |
9 |
0.0056 |
| 292 |
CLOSTRIDIUM DIFFICILE COLITIS |
59 |
0.0056 |
| 293 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
57 |
0.0055 |
| 294 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
13 |
0.0055 |
| 295 |
MULTIPLE-DRUG RESISTANCE |
17 |
0.0055 |
| 296 |
DERMATITIS EXFOLIATIVE GENERALISED |
19 |
0.0055 |
| 297 |
SERUM SICKNESS |
15 |
0.0054 |
| 298 |
MYOCARDIAL NECROSIS MARKER INCREASED |
9 |
0.0054 |
| 299 |
ESCHERICHIA INFECTION |
44 |
0.0053 |
| 300 |
VARICELLA ZOSTER VIRUS INFECTION |
11 |
0.0053 |
| 301 |
TRANSPLANT FAILURE |
13 |
0.0053 |
| 302 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
46 |
0.0053 |
| 303 |
MYCOBACTERIAL INFECTION |
9 |
0.0052 |
| 304 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
14 |
0.0052 |
| 305 |
ORGAN FAILURE |
21 |
0.0052 |
| 306 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
92 |
0.0052 |
| 307 |
CYTOMEGALOVIRUS CHORIORETINITIS |
10 |
0.0051 |
| 308 |
RASH MACULO-PAPULAR |
114 |
0.0051 |
| 309 |
ENCEPHALOPATHY |
125 |
0.0051 |
| 310 |
VASCULAR DEVICE INFECTION |
23 |
0.0051 |
| 311 |
MUCOSAL INFLAMMATION |
132 |
0.0050 |
| 312 |
PROCTITIS |
14 |
0.0050 |
| 313 |
TRANSPLANT REJECTION |
40 |
0.0050 |
| 314 |
HEPATITIS TOXIC |
13 |
0.0050 |
| 315 |
THROMBOCYTOPENIA |
551 |
0.0049 |
| 316 |
ENDOCARDITIS |
25 |
0.0049 |
| 317 |
OTOTOXICITY |
9 |
0.0049 |
| 318 |
VITRITIS |
9 |
0.0049 |
| 319 |
ENTERITIS |
31 |
0.0048 |
| 320 |
JAUNDICE CHOLESTATIC |
17 |
0.0048 |
| 321 |
LUNG TRANSPLANT |
17 |
0.0048 |
| 322 |
CHOLECYSTITIS ACUTE |
27 |
0.0048 |
| 323 |
CEREBRAL HAEMATOMA |
16 |
0.0048 |
| 324 |
NEUROLOGICAL DECOMPENSATION |
11 |
0.0047 |
| 325 |
CUSHINGOID |
15 |
0.0047 |
| 326 |
LYMPHOPENIA |
66 |
0.0047 |
| 327 |
PULMONARY ALVEOLAR HAEMORRHAGE |
26 |
0.0046 |
| 328 |
CARDIAC DYSFUNCTION |
17 |
0.0046 |
| 329 |
CATHETER SITE INFECTION |
17 |
0.0045 |
| 330 |
POTENTIATING DRUG INTERACTION |
15 |
0.0045 |
| 331 |
TONGUE ULCERATION |
15 |
0.0044 |
| 332 |
PERICARDIAL EFFUSION |
102 |
0.0044 |
| 333 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
39 |
0.0044 |
| 334 |
GASTROINTESTINAL TUBE INSERTION |
11 |
0.0044 |
| 335 |
STAPHYLOCOCCAL INFECTION |
145 |
0.0044 |
| 336 |
SERUM FERRITIN INCREASED |
23 |
0.0044 |
| 337 |
PNEUMONIA BACTERIAL |
40 |
0.0044 |
| 338 |
PRODUCT USE IN UNAPPROVED INDICATION |
1074 |
0.0043 |
| 339 |
METABOLIC ENCEPHALOPATHY |
13 |
0.0043 |
| 340 |
HEPATITIS CHOLESTATIC |
26 |
0.0043 |
| 341 |
LIVER ABSCESS |
14 |
0.0043 |
| 342 |
HAEMOLYTIC URAEMIC SYNDROME |
10 |
0.0043 |
| 343 |
ELECTROLYTE IMBALANCE |
49 |
0.0042 |
| 344 |
MALABSORPTION |
22 |
0.0042 |
| 345 |
IMMUNOSUPPRESSION |
37 |
0.0042 |
| 346 |
EXOPHTHALMOS |
9 |
0.0042 |
| 347 |
HYPOXIA |
147 |
0.0042 |
| 348 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
66 |
0.0042 |
| 349 |
AGRANULOCYTOSIS |
77 |
0.0041 |
| 350 |
ORAL DISORDER |
30 |
0.0041 |
| 351 |
RED CELL DISTRIBUTION WIDTH INCREASED |
17 |
0.0041 |
| 352 |
MYELODYSPLASTIC SYNDROME |
59 |
0.0041 |
| 353 |
BRAIN OEDEMA |
51 |
0.0040 |
| 354 |
PULMONARY MASS |
60 |
0.0040 |
| 355 |
BLOOD BILIRUBIN INCREASED |
108 |
0.0040 |
| 356 |
MULTI-ORGAN FAILURE |
69 |
0.0040 |
| 357 |
HYPOALBUMINAEMIA |
31 |
0.0040 |
| 358 |
CHRONIC GASTRITIS |
9 |
0.0040 |
| 359 |
PULMONARY HAEMORRHAGE |
31 |
0.0040 |
| 360 |
HEPATIC LESION |
17 |
0.0039 |
| 361 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
20 |
0.0039 |
| 362 |
ENDOTRACHEAL INTUBATION |
11 |
0.0039 |
| 363 |
ISCHAEMIC CARDIOMYOPATHY |
12 |
0.0039 |
| 364 |
TRANSFUSION |
41 |
0.0039 |
| 365 |
TRANSAMINASES INCREASED |
87 |
0.0039 |
| 366 |
DISSEMINATED INTRAVASCULAR COAGULATION |
55 |
0.0039 |
| 367 |
MYELOSUPPRESSION |
140 |
0.0039 |
| 368 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
9 |
0.0039 |
| 369 |
PARONYCHIA |
17 |
0.0039 |
| 370 |
RESPIRATORY FAILURE |
282 |
0.0039 |
| 371 |
NEUROLOGICAL SYMPTOM |
22 |
0.0038 |
| 372 |
DRUG-INDUCED LIVER INJURY |
120 |
0.0038 |
| 373 |
SEPSIS |
425 |
0.0038 |
| 374 |
AREFLEXIA |
10 |
0.0037 |
| 375 |
SINUS BRADYCARDIA |
36 |
0.0037 |
| 376 |
ACUTE RESPIRATORY FAILURE |
71 |
0.0037 |
| 377 |
RENAL TUBULAR NECROSIS |
36 |
0.0037 |
| 378 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
14 |
0.0037 |
| 379 |
FAILURE TO THRIVE |
19 |
0.0037 |
| 380 |
ENCEPHALITIS |
25 |
0.0036 |
| 381 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
89 |
0.0036 |
| 382 |
MONOCYTE COUNT INCREASED |
13 |
0.0036 |
| 383 |
CARDIAC TAMPONADE |
17 |
0.0036 |
| 384 |
HEPATOMEGALY |
35 |
0.0036 |
| 385 |
OLIGURIA |
22 |
0.0035 |
| 386 |
NEUTROPHIL COUNT ABNORMAL |
10 |
0.0035 |
| 387 |
RETINAL HAEMORRHAGE |
25 |
0.0035 |
| 388 |
BRONCHOPNEUMONIA |
12 |
0.0035 |
| 389 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
35 |
0.0035 |
| 390 |
TOXIC SKIN ERUPTION |
35 |
0.0035 |
| 391 |
VITAMIN B12 DECREASED |
10 |
0.0035 |
| 392 |
NEUTROPHIL COUNT DECREASED |
141 |
0.0035 |
| 393 |
HYPERVOLAEMIA |
17 |
0.0034 |
| 394 |
HYPOVENTILATION |
11 |
0.0034 |
| 395 |
TOXIC ENCEPHALOPATHY |
17 |
0.0034 |
| 396 |
CENTRAL NERVOUS SYSTEM LESION |
46 |
0.0033 |
| 397 |
CENTRAL VENOUS CATHETERISATION |
10 |
0.0033 |
| 398 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
18 |
0.0033 |
| 399 |
HYPERTRANSAMINASAEMIA |
23 |
0.0033 |
| 400 |
CARDIAC FAILURE ACUTE |
22 |
0.0033 |
| 401 |
HEPATIC FAILURE |
99 |
0.0033 |
| 402 |
HAEMODYNAMIC INSTABILITY |
25 |
0.0033 |
| 403 |
AMYLASE INCREASED |
12 |
0.0032 |
| 404 |
CANDIDIASIS |
13 |
0.0032 |
| 405 |
DIASTOLIC DYSFUNCTION |
10 |
0.0032 |
| 406 |
MALNUTRITION |
36 |
0.0032 |
| 407 |
HYPERNATRAEMIA |
16 |
0.0032 |
| 408 |
PERIPHERAL VENOUS DISEASE |
13 |
0.0032 |
| 409 |
BLOOD CREATININE ABNORMAL |
11 |
0.0032 |
| 410 |
GENERALISED OEDEMA |
39 |
0.0031 |
| 411 |
PAPULE |
22 |
0.0031 |
| 412 |
CACHEXIA |
16 |
0.0031 |
| 413 |
IMMUNODEFICIENCY |
46 |
0.0031 |
| 414 |
HYPERPYREXIA |
13 |
0.0031 |
| 415 |
ILEUS |
38 |
0.0031 |
| 416 |
ADRENAL INSUFFICIENCY |
37 |
0.0030 |
| 417 |
TOXIC EPIDERMAL NECROLYSIS |
46 |
0.0030 |
| 418 |
SCLERODERMA |
11 |
0.0030 |
| 419 |
ACUTE KIDNEY INJURY |
462 |
0.0030 |
| 420 |
BLOOD PHOSPHORUS DECREASED |
11 |
0.0030 |
| 421 |
DERMATITIS EXFOLIATIVE |
15 |
0.0030 |
| 422 |
LEFT VENTRICULAR DYSFUNCTION |
20 |
0.0030 |
| 423 |
PULMONARY FUNCTION TEST DECREASED |
13 |
0.0030 |
| 424 |
ANAL ABSCESS |
16 |
0.0030 |
| 425 |
PLEURAL EFFUSION |
179 |
0.0029 |
| 426 |
BLOOD PHOSPHORUS INCREASED |
8 |
0.0029 |
| 427 |
LEUKOCYTOSIS |
53 |
0.0029 |
| 428 |
PROTEIN TOTAL DECREASED |
11 |
0.0029 |
| 429 |
APLASIA PURE RED CELL |
10 |
0.0029 |
| 430 |
LUNG INFECTION |
45 |
0.0029 |
| 431 |
VENTRICULAR FIBRILLATION |
32 |
0.0029 |
| 432 |
PLATELET COUNT DECREASED |
306 |
0.0029 |
| 433 |
IRIDOCYCLITIS |
9 |
0.0028 |
| 434 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
10 |
0.0028 |
| 435 |
SHOCK HAEMORRHAGIC |
23 |
0.0028 |
| 436 |
ESCHERICHIA URINARY TRACT INFECTION |
12 |
0.0028 |
| 437 |
SQUAMOUS CELL CARCINOMA OF SKIN |
17 |
0.0028 |
| 438 |
HYPERAMMONAEMIA |
14 |
0.0028 |
| 439 |
BLOOD ALBUMIN DECREASED |
22 |
0.0028 |
| 440 |
AZOTAEMIA |
11 |
0.0028 |
| 441 |
RESPIRATORY DISTRESS |
75 |
0.0027 |
| 442 |
SKIN MASS |
18 |
0.0027 |
| 443 |
NECROSIS |
15 |
0.0027 |
| 444 |
ARTHRITIS BACTERIAL |
11 |
0.0027 |
| 445 |
SKIN INFECTION |
30 |
0.0027 |
| 446 |
BLOOD CULTURE POSITIVE |
8 |
0.0027 |
| 447 |
CATATONIA |
14 |
0.0027 |
| 448 |
PYREXIA |
921 |
0.0027 |
| 449 |
DRUG ERUPTION |
47 |
0.0026 |
| 450 |
DISEASE PROGRESSION |
313 |
0.0026 |
| 451 |
PROCTALGIA |
17 |
0.0026 |
| 452 |
FULL BLOOD COUNT DECREASED |
53 |
0.0026 |
| 453 |
RED BLOOD CELL COUNT DECREASED |
75 |
0.0026 |
| 454 |
HYPERTHERMIA |
20 |
0.0026 |
| 455 |
ABDOMINAL TENDERNESS |
13 |
0.0026 |
| 456 |
CONJUNCTIVAL HAEMORRHAGE |
10 |
0.0026 |
| 457 |
PURPURA |
23 |
0.0026 |
| 458 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
8 |
0.0026 |
| 459 |
MENTAL STATUS CHANGES |
72 |
0.0026 |
| 460 |
LARGE INTESTINE PERFORATION |
18 |
0.0026 |
| 461 |
DECUBITUS ULCER |
21 |
0.0026 |
| 462 |
VASCULITIS |
30 |
0.0026 |
| 463 |
PURULENT DISCHARGE |
11 |
0.0026 |
| 464 |
BLOOD MAGNESIUM DECREASED |
22 |
0.0025 |
| 465 |
MYOPATHY |
22 |
0.0025 |
| 466 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
139 |
0.0025 |
| 467 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
12 |
0.0025 |
| 468 |
HAEMOPTYSIS |
70 |
0.0025 |
| 469 |
PANCREATITIS ACUTE |
56 |
0.0025 |
| 470 |
LIVER FUNCTION TEST ABNORMAL |
72 |
0.0025 |
| 471 |
CLOSTRIDIUM DIFFICILE INFECTION |
54 |
0.0025 |
| 472 |
HEPATITIS ACUTE |
16 |
0.0025 |
| 473 |
COVID-19 PNEUMONIA |
29 |
0.0025 |
| 474 |
THROMBOCYTOSIS |
9 |
0.0025 |
| 475 |
EJECTION FRACTION DECREASED |
38 |
0.0024 |
| 476 |
BLOOD COUNT ABNORMAL |
37 |
0.0024 |
| 477 |
SUSPECTED OFF LABEL USE |
11 |
0.0024 |
| 478 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
12 |
0.0024 |
| 479 |
HEPATIC ENZYME ABNORMAL |
12 |
0.0024 |
| 480 |
PULSELESS ELECTRICAL ACTIVITY |
10 |
0.0024 |
| 481 |
HYPERTRIGLYCERIDAEMIA |
14 |
0.0024 |
| 482 |
CHEMOTHERAPY |
9 |
0.0024 |
| 483 |
HALLUCINATIONS, MIXED |
10 |
0.0024 |
| 484 |
ABSCESS LIMB |
10 |
0.0023 |
| 485 |
HAEMOLYSIS |
18 |
0.0023 |
| 486 |
OCULAR ICTERUS |
10 |
0.0023 |
| 487 |
VENTRICULAR TACHYCARDIA |
38 |
0.0023 |
| 488 |
LIVER INJURY |
56 |
0.0023 |
| 489 |
HEPATIC FUNCTION ABNORMAL |
85 |
0.0023 |
| 490 |
ATELECTASIS |
22 |
0.0023 |
| 491 |
MENINGITIS |
15 |
0.0022 |
| 492 |
ASCITES |
66 |
0.0022 |
| 493 |
GASTROINTESTINAL INFECTION |
20 |
0.0022 |
| 494 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
38 |
0.0022 |
| 495 |
ANURIA |
19 |
0.0022 |
| 496 |
PETECHIAE |
23 |
0.0022 |
| 497 |
ORAL HERPES |
43 |
0.0022 |
| 498 |
ORAL CANDIDIASIS |
29 |
0.0022 |
| 499 |
FOLLICULITIS |
23 |
0.0022 |
| 500 |
FULL BLOOD COUNT ABNORMAL |
23 |
0.0022 |
| 501 |
SUBDURAL HAEMATOMA |
31 |
0.0022 |
| 502 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
16 |
0.0022 |
| 503 |
CELLULITIS |
109 |
0.0022 |
| 504 |
PNEUMONIA |
698 |
0.0022 |
| 505 |
SKIN LESION |
59 |
0.0021 |
| 506 |
PLATELET COUNT ABNORMAL |
13 |
0.0021 |
| 507 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
55 |
0.0021 |
| 508 |
HALLUCINATION, VISUAL |
45 |
0.0021 |
| 509 |
HYPONATRAEMIA |
120 |
0.0021 |
| 510 |
INFECTION |
304 |
0.0021 |
| 511 |
LIPASE INCREASED |
16 |
0.0021 |
| 512 |
GUILLAIN-BARRE SYNDROME |
10 |
0.0021 |
| 513 |
RENAL FAILURE |
274 |
0.0021 |
| 514 |
C-REACTIVE PROTEIN INCREASED |
75 |
0.0021 |
| 515 |
LEUKOPENIA |
103 |
0.0021 |
| 516 |
GINGIVAL BLEEDING |
28 |
0.0020 |
| 517 |
SPLENOMEGALY |
24 |
0.0020 |
| 518 |
ASPARTATE AMINOTRANSFERASE INCREASED |
108 |
0.0020 |
| 519 |
RENAL IMPAIRMENT |
169 |
0.0020 |
| 520 |
POLYNEUROPATHY |
24 |
0.0020 |
| 521 |
ALANINE AMINOTRANSFERASE INCREASED |
123 |
0.0020 |
| 522 |
HAEMATOTOXICITY |
19 |
0.0020 |
| 523 |
CYSTIC FIBROSIS |
11 |
0.0020 |
| 524 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
44 |
0.0020 |
| 525 |
TREATMENT FAILURE |
163 |
0.0020 |
| 526 |
HAEMATOCRIT DECREASED |
39 |
0.0020 |
| 527 |
IMMUNE THROMBOCYTOPENIA |
9 |
0.0020 |
| 528 |
LIVER FUNCTION TEST INCREASED |
42 |
0.0020 |
| 529 |
OFF LABEL USE |
1706 |
0.0019 |
| 530 |
ATRIOVENTRICULAR BLOCK |
15 |
0.0019 |
| 531 |
PERIORBITAL OEDEMA |
10 |
0.0019 |
| 532 |
FLUID OVERLOAD |
28 |
0.0019 |
| 533 |
COAGULOPATHY |
32 |
0.0019 |
| 534 |
ASPIRATION |
21 |
0.0019 |
| 535 |
CARDIOMYOPATHY |
28 |
0.0019 |
| 536 |
RALES |
11 |
0.0019 |
| 537 |
OBSTRUCTIVE AIRWAYS DISORDER |
21 |
0.0019 |
| 538 |
ABSCESS |
30 |
0.0019 |
| 539 |
SUBCUTANEOUS ABSCESS |
9 |
0.0019 |
| 540 |
WHITE BLOOD CELL COUNT DECREASED |
203 |
0.0019 |
| 541 |
HAEMOGLOBIN ABNORMAL |
12 |
0.0019 |
| 542 |
BRAIN FOG |
29 |
0.0018 |
| 543 |
COLITIS |
70 |
0.0018 |
| 544 |
INCORRECT DOSAGE ADMINISTERED |
9 |
0.0018 |
| 545 |
TROPONIN INCREASED |
14 |
0.0018 |
| 546 |
NODULE |
24 |
0.0018 |
| 547 |
TACHYPNOEA |
25 |
0.0018 |
| 548 |
HYPOPHAGIA |
47 |
0.0018 |
| 549 |
FACE OEDEMA |
31 |
0.0018 |
| 550 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
15 |
0.0018 |
| 551 |
DIFFUSE LARGE B-CELL LYMPHOMA |
14 |
0.0018 |
| 552 |
INFLAMMATORY MARKER INCREASED |
9 |
0.0018 |
| 553 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
13 |
0.0018 |
| 554 |
SQUAMOUS CELL CARCINOMA |
17 |
0.0018 |
| 555 |
HEPATITIS |
46 |
0.0018 |
| 556 |
HYPOCALCAEMIA |
34 |
0.0018 |
| 557 |
RESPIRATORY DISORDER |
53 |
0.0018 |
| 558 |
STATUS EPILEPTICUS |
20 |
0.0018 |
| 559 |
PHOTOSENSITIVITY REACTION |
29 |
0.0018 |
| 560 |
HYDRONEPHROSIS |
13 |
0.0017 |
| 561 |
RHINITIS |
14 |
0.0017 |
| 562 |
HERPES VIRUS INFECTION |
10 |
0.0017 |
| 563 |
BLOOD URIC ACID INCREASED |
10 |
0.0017 |
| 564 |
BLOOD CREATININE INCREASED |
113 |
0.0017 |
| 565 |
RESPIRATORY TRACT INFECTION |
45 |
0.0017 |
| 566 |
PARTIAL SEIZURES |
9 |
0.0017 |
| 567 |
BRADYCARDIA |
91 |
0.0017 |
| 568 |
MOUTH ULCERATION |
36 |
0.0017 |
| 569 |
DELIRIUM |
59 |
0.0017 |
| 570 |
SINUS TACHYCARDIA |
24 |
0.0017 |
| 571 |
ANAL FISTULA |
9 |
0.0017 |
| 572 |
HYPOTHERMIA |
17 |
0.0017 |
| 573 |
MITRAL VALVE INCOMPETENCE |
19 |
0.0017 |
| 574 |
ANAEMIA |
320 |
0.0017 |
| 575 |
CEREBRAL HAEMORRHAGE |
60 |
0.0017 |
| 576 |
ODYNOPHAGIA |
10 |
0.0017 |
| 577 |
HAEMOLYTIC ANAEMIA |
15 |
0.0017 |
| 578 |
CARDIOGENIC SHOCK |
24 |
0.0017 |
| 579 |
CARDIAC ARREST |
138 |
0.0017 |
| 580 |
HAEMOGLOBIN DECREASED |
170 |
0.0017 |
| 581 |
RHABDOMYOLYSIS |
69 |
0.0017 |
| 582 |
LUNG DISORDER |
81 |
0.0017 |
| 583 |
PNEUMONITIS |
45 |
0.0017 |
| 584 |
CIRCULATORY COLLAPSE |
28 |
0.0016 |
| 585 |
TRICUSPID VALVE INCOMPETENCE |
13 |
0.0016 |
| 586 |
INTESTINAL ISCHAEMIA |
9 |
0.0016 |
| 587 |
HYPERKALAEMIA |
57 |
0.0016 |
| 588 |
NEPHROTIC SYNDROME |
11 |
0.0016 |
| 589 |
HEPATIC ENZYME INCREASED |
109 |
0.0016 |
| 590 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
8 |
0.0016 |
| 591 |
MYOCARDITIS |
18 |
0.0016 |
| 592 |
ACIDOSIS |
12 |
0.0016 |
| 593 |
WHITE BLOOD CELL COUNT ABNORMAL |
10 |
0.0016 |
| 594 |
SKIN ATROPHY |
9 |
0.0016 |
| 595 |
PULMONARY OEDEMA |
70 |
0.0016 |
| 596 |
BLOOD UREA INCREASED |
26 |
0.0016 |
| 597 |
VENTRICULAR EXTRASYSTOLES |
16 |
0.0015 |
| 598 |
ACUTE HEPATIC FAILURE |
21 |
0.0015 |
| 599 |
TASTE DISORDER |
31 |
0.0015 |
| 600 |
JAUNDICE |
41 |
0.0015 |
| 601 |
ATAXIA |
18 |
0.0015 |
| 602 |
CORONAVIRUS INFECTION |
10 |
0.0015 |
| 603 |
PROTHROMBIN TIME PROLONGED |
9 |
0.0015 |
| 604 |
MUSCLE ATROPHY |
19 |
0.0015 |
| 605 |
BLOOD DISORDER |
12 |
0.0015 |
| 606 |
PRODUCT USE ISSUE |
281 |
0.0015 |
| 607 |
OEDEMA |
81 |
0.0015 |
| 608 |
CONDITION AGGRAVATED |
449 |
0.0015 |
| 609 |
VIRAL INFECTION |
49 |
0.0015 |
| 610 |
POLYURIA |
12 |
0.0015 |
| 611 |
HAEMATURIA |
50 |
0.0015 |
| 612 |
ECCHYMOSIS |
10 |
0.0015 |
| 613 |
TACHYCARDIA |
129 |
0.0015 |
| 614 |
DIZZINESS POSTURAL |
14 |
0.0014 |
| 615 |
METABOLIC ACIDOSIS |
46 |
0.0014 |
| 616 |
HAEMORRHOIDS |
28 |
0.0014 |
| 617 |
ADVERSE EVENT |
132 |
0.0014 |
| 618 |
BLOOD POTASSIUM DECREASED |
43 |
0.0014 |
| 619 |
CHOLECYSTITIS |
17 |
0.0014 |
| 620 |
BLOOD CALCIUM DECREASED |
16 |
0.0014 |
| 621 |
THERAPY PARTIAL RESPONDER |
22 |
0.0014 |
| 622 |
MELAENA |
31 |
0.0014 |
| 623 |
GASTROINTESTINAL INFLAMMATION |
11 |
0.0014 |
| 624 |
PRODUCT DISTRIBUTION ISSUE |
13 |
0.0014 |
| 625 |
SKIN HYPERPIGMENTATION |
12 |
0.0014 |
| 626 |
NO THERAPEUTIC RESPONSE |
17 |
0.0014 |
| 627 |
GENERAL PHYSICAL HEALTH DETERIORATION |
160 |
0.0014 |
| 628 |
HYPERCALCAEMIA |
17 |
0.0014 |
| 629 |
FAECES SOFT |
10 |
0.0014 |
| 630 |
HYPERGLYCAEMIA |
50 |
0.0014 |
| 631 |
MAJOR DEPRESSION |
10 |
0.0014 |
| 632 |
DISEASE RECURRENCE |
65 |
0.0014 |
| 633 |
LYMPHOCYTE COUNT DECREASED |
24 |
0.0014 |
| 634 |
STEVENS-JOHNSON SYNDROME |
30 |
0.0013 |
| 635 |
ANAL INCONTINENCE |
12 |
0.0013 |
| 636 |
ORTHOSTATIC HYPOTENSION |
23 |
0.0013 |
| 637 |
RENAL DISORDER |
61 |
0.0013 |
| 638 |
LIVER DISORDER |
58 |
0.0013 |
| 639 |
JOINT EFFUSION |
9 |
0.0013 |
| 640 |
NEOPLASM |
15 |
0.0013 |
| 641 |
NEUROPATHY PERIPHERAL |
124 |
0.0013 |
| 642 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
51 |
0.0013 |
| 643 |
EMPHYSEMA |
13 |
0.0013 |
| 644 |
HALLUCINATION |
97 |
0.0013 |
| 645 |
HEPATIC ENCEPHALOPATHY |
12 |
0.0013 |
| 646 |
OESOPHAGITIS |
14 |
0.0013 |
| 647 |
SUBARACHNOID HAEMORRHAGE |
13 |
0.0013 |
| 648 |
THERAPY NON-RESPONDER |
57 |
0.0013 |
| 649 |
PNEUMOTHORAX |
20 |
0.0013 |
| 650 |
URINE OUTPUT DECREASED |
11 |
0.0013 |
| 651 |
ATRIAL FLUTTER |
10 |
0.0013 |
| 652 |
INTESTINAL PERFORATION |
14 |
0.0012 |
| 653 |
ATRIAL FIBRILLATION |
120 |
0.0012 |
| 654 |
MYOCARDIAL ISCHAEMIA |
14 |
0.0012 |
| 655 |
TOXICITY TO VARIOUS AGENTS |
205 |
0.0012 |
| 656 |
GASTROINTESTINAL HAEMORRHAGE |
101 |
0.0012 |
| 657 |
ACUTE CORONARY SYNDROME |
10 |
0.0012 |
| 658 |
HAEMORRHAGE INTRACRANIAL |
18 |
0.0012 |
| 659 |
CARDIAC FAILURE |
96 |
0.0012 |
| 660 |
PRODUCT PRESCRIBING ISSUE |
26 |
0.0012 |
| 661 |
APPENDICITIS |
11 |
0.0012 |
| 662 |
SHOCK |
27 |
0.0012 |
| 663 |
PULMONARY ARTERIAL HYPERTENSION |
17 |
0.0012 |
| 664 |
HYPOTENSION |
235 |
0.0012 |
| 665 |
EPISTAXIS |
87 |
0.0012 |
| 666 |
NERVOUS SYSTEM DISORDER |
36 |
0.0012 |
| 667 |
DEATH |
993 |
0.0012 |
| 668 |
LABORATORY TEST ABNORMAL |
34 |
0.0012 |
| 669 |
SUPRAVENTRICULAR TACHYCARDIA |
11 |
0.0011 |
| 670 |
DRUG INEFFECTIVE |
1513 |
0.0011 |
| 671 |
INTERNAL HAEMORRHAGE |
13 |
0.0011 |
| 672 |
SUDDEN DEATH |
12 |
0.0011 |
| 673 |
PERICARDITIS |
19 |
0.0011 |
| 674 |
GINGIVAL PAIN |
9 |
0.0011 |
| 675 |
HAEMORRHAGE |
118 |
0.0011 |
| 676 |
RENAL FAILURE ACUTE |
47 |
0.0011 |
| 677 |
MUSCULAR WEAKNESS |
125 |
0.0011 |
| 678 |
BRAIN INJURY |
11 |
0.0011 |
| 679 |
WHITE BLOOD CELL COUNT INCREASED |
42 |
0.0011 |
| 680 |
APHASIA |
33 |
0.0011 |
| 681 |
CARDIAC FAILURE CONGESTIVE |
87 |
0.0011 |
| 682 |
BODY TEMPERATURE INCREASED |
22 |
0.0011 |
| 683 |
DRUG INTOLERANCE |
104 |
0.0011 |
| 684 |
ERYTHEMA MULTIFORME |
10 |
0.0011 |
| 685 |
BLOOD TEST ABNORMAL |
15 |
0.0011 |
| 686 |
PULMONARY EMBOLISM |
101 |
0.0011 |
| 687 |
HEMIPARESIS |
18 |
0.0011 |
| 688 |
BLOOD PRESSURE ABNORMAL |
21 |
0.0011 |
| 689 |
PRODUCT AVAILABILITY ISSUE |
24 |
0.0011 |
| 690 |
AORTIC ANEURYSM |
8 |
0.0011 |
| 691 |
LACTIC ACIDOSIS |
34 |
0.0010 |
| 692 |
OEDEMA PERIPHERAL |
126 |
0.0010 |
| 693 |
DEEP VEIN THROMBOSIS |
67 |
0.0010 |
| 694 |
COMA |
49 |
0.0010 |
| 695 |
PRESYNCOPE |
25 |
0.0010 |
| 696 |
ARRHYTHMIA |
48 |
0.0010 |
| 697 |
INTERSTITIAL LUNG DISEASE |
49 |
0.0010 |
| 698 |
HYPERTENSIVE CRISIS |
11 |
0.0010 |
| 699 |
LYMPHADENOPATHY |
35 |
0.0010 |
| 700 |
CHILLS |
115 |
0.0010 |
| 701 |
CARDIO-RESPIRATORY ARREST |
41 |
0.0010 |
| 702 |
ABNORMAL FAECES |
8 |
0.0010 |
| 703 |
SMALL INTESTINAL OBSTRUCTION |
12 |
0.0010 |
| 704 |
EOSINOPHILIA |
17 |
0.0010 |
| 705 |
PHARYNGITIS |
12 |
0.0010 |
| 706 |
SCAB |
11 |
0.0010 |
| 707 |
TUBULOINTERSTITIAL NEPHRITIS |
18 |
0.0010 |
| 708 |
CONTRAINDICATED PRODUCT ADMINISTERED |
29 |
0.0010 |
| 709 |
RENAL INJURY |
28 |
0.0009 |
| 710 |
CYSTITIS |
30 |
0.0009 |
| 711 |
DECREASED APPETITE |
217 |
0.0009 |
| 712 |
DYSPNOEA EXERTIONAL |
35 |
0.0009 |
| 713 |
ALTERED STATE OF CONSCIOUSNESS |
20 |
0.0009 |
| 714 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
27 |
0.0009 |
| 715 |
NEOPLASM PROGRESSION |
32 |
0.0009 |
| 716 |
LOCALISED INFECTION |
22 |
0.0009 |
| 717 |
PANCREATITIS |
48 |
0.0009 |
| 718 |
GENERALISED TONIC-CLONIC SEIZURE |
15 |
0.0009 |
| 719 |
HYPERTENSION |
192 |
0.0009 |
| 720 |
BLOOD SODIUM DECREASED |
17 |
0.0009 |
| 721 |
ISCHAEMIC STROKE |
16 |
0.0009 |
| 722 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
15 |
0.0009 |
| 723 |
SKIN ULCER |
23 |
0.0009 |
| 724 |
COVID-19 |
156 |
0.0009 |
| 725 |
OSTEOMYELITIS |
16 |
0.0009 |
| 726 |
STOMATITIS |
53 |
0.0009 |
| 727 |
URINARY TRACT INFECTION |
149 |
0.0009 |
| 728 |
GASTROINTESTINAL DISORDER |
78 |
0.0009 |
| 729 |
INTENTIONAL PRODUCT USE ISSUE |
76 |
0.0009 |
| 730 |
HEPATIC STEATOSIS |
16 |
0.0009 |
| 731 |
DISORIENTATION |
34 |
0.0009 |
| 732 |
DIARRHOEA |
550 |
0.0009 |
| 733 |
EPILEPSY |
26 |
0.0008 |
| 734 |
HIATUS HERNIA |
11 |
0.0008 |
| 735 |
HAEMATOMA |
22 |
0.0008 |
| 736 |
FLUID RETENTION |
43 |
0.0008 |
| 737 |
PLATELET COUNT INCREASED |
11 |
0.0008 |
| 738 |
GASTRIC ULCER |
16 |
0.0008 |
| 739 |
URINARY RETENTION |
28 |
0.0008 |
| 740 |
OXYGEN SATURATION DECREASED |
47 |
0.0008 |
| 741 |
TYPE 2 DIABETES MELLITUS |
28 |
0.0008 |
| 742 |
DIVERTICULITIS |
23 |
0.0008 |
| 743 |
PULMONARY THROMBOSIS |
9 |
0.0008 |
| 744 |
NEURALGIA |
20 |
0.0008 |
| 745 |
WOUND INFECTION |
9 |
0.0008 |
| 746 |
SINUSITIS |
84 |
0.0008 |
| 747 |
ABDOMINAL PAIN |
190 |
0.0008 |
| 748 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
58 |
0.0008 |
| 749 |
ORAL PAIN |
18 |
0.0008 |
| 750 |
CONSTIPATION |
173 |
0.0008 |
| 751 |
ASTHENIA |
298 |
0.0008 |
| 752 |
HAEMATEMESIS |
20 |
0.0008 |
| 753 |
CONFUSIONAL STATE |
126 |
0.0008 |
| 754 |
DIALYSIS |
11 |
0.0008 |
| 755 |
PRODUCTIVE COUGH |
37 |
0.0008 |
| 756 |
TENDONITIS |
12 |
0.0008 |
| 757 |
UNRESPONSIVE TO STIMULI |
20 |
0.0008 |
| 758 |
BRONCHOSPASM |
11 |
0.0008 |
| 759 |
PULMONARY HYPERTENSION |
16 |
0.0008 |
| 760 |
DRY EYE |
38 |
0.0008 |
| 761 |
UPPER RESPIRATORY TRACT INFECTION |
35 |
0.0008 |
| 762 |
HOSPITALISATION |
116 |
0.0008 |
| 763 |
GASTROENTERITIS |
11 |
0.0008 |
| 764 |
MALIGNANT MELANOMA |
10 |
0.0007 |
| 765 |
BLOOD POTASSIUM INCREASED |
12 |
0.0007 |
| 766 |
PROTEINURIA |
14 |
0.0007 |
| 767 |
INFLAMMATION |
38 |
0.0007 |
| 768 |
DRUG TOXICITY |
10 |
0.0007 |
| 769 |
VOMITING |
343 |
0.0007 |
| 770 |
DEHYDRATION |
96 |
0.0007 |
| 771 |
SKIN DISORDER |
24 |
0.0007 |
| 772 |
COUGH |
200 |
0.0007 |
| 773 |
BLINDNESS UNILATERAL |
10 |
0.0007 |
| 774 |
CHROMATURIA |
16 |
0.0007 |
| 775 |
OSTEOPOROSIS |
29 |
0.0007 |
| 776 |
MYDRIASIS |
9 |
0.0007 |
| 777 |
PARALYSIS |
10 |
0.0007 |
| 778 |
LETHARGY |
40 |
0.0007 |
| 779 |
SEIZURE |
80 |
0.0007 |
| 780 |
FEEDING DISORDER |
14 |
0.0007 |
| 781 |
DRUG EFFECT INCOMPLETE |
25 |
0.0007 |
| 782 |
TOOTH INFECTION |
9 |
0.0007 |
| 783 |
SYNCOPE |
68 |
0.0007 |
| 784 |
ACUTE MYOCARDIAL INFARCTION |
20 |
0.0007 |
| 785 |
NAUSEA |
536 |
0.0007 |
| 786 |
POST PROCEDURAL COMPLICATION |
13 |
0.0007 |
| 787 |
VISUAL IMPAIRMENT |
83 |
0.0007 |
| 788 |
PLASMA CELL MYELOMA |
26 |
0.0007 |
| 789 |
BONE PAIN |
39 |
0.0007 |
| 790 |
BLINDNESS |
27 |
0.0007 |
| 791 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
19 |
0.0007 |
| 792 |
ABDOMINAL DISTENSION |
68 |
0.0007 |
| 793 |
INFLUENZA |
72 |
0.0006 |
| 794 |
PNEUMONIA ASPIRATION |
16 |
0.0006 |
| 795 |
SKIN EXFOLIATION |
54 |
0.0006 |
| 796 |
LOWER RESPIRATORY TRACT INFECTION |
29 |
0.0006 |
| 797 |
TREMOR |
105 |
0.0006 |
| 798 |
PERITONITIS |
13 |
0.0006 |
| 799 |
RASH PRURITIC |
34 |
0.0006 |
| 800 |
PALLOR |
17 |
0.0006 |
| 801 |
MYALGIA |
106 |
0.0006 |
| 802 |
PRESCRIBED OVERDOSE |
12 |
0.0006 |
| 803 |
CEREBRAL INFARCTION |
15 |
0.0006 |
| 804 |
CHOLELITHIASIS |
20 |
0.0006 |
| 805 |
DYSPNOEA |
344 |
0.0006 |
| 806 |
SKIN HAEMORRHAGE |
9 |
0.0006 |
| 807 |
CATARACT |
36 |
0.0006 |
| 808 |
SKIN CANCER |
13 |
0.0006 |
| 809 |
AGEUSIA |
15 |
0.0006 |
| 810 |
NO ADVERSE EVENT |
108 |
0.0006 |
| 811 |
CONJUNCTIVITIS |
11 |
0.0006 |
| 812 |
INSURANCE ISSUE |
9 |
0.0006 |
| 813 |
RASH ERYTHEMATOUS |
28 |
0.0006 |
| 814 |
MUSCULOSKELETAL CHEST PAIN |
9 |
0.0006 |
| 815 |
THERAPEUTIC RESPONSE DECREASED |
35 |
0.0006 |
| 816 |
DERMATITIS |
12 |
0.0006 |
| 817 |
MUSCULOSKELETAL PAIN |
30 |
0.0006 |
| 818 |
FATIGUE |
443 |
0.0006 |
| 819 |
PERIPHERAL SWELLING |
87 |
0.0006 |
| 820 |
CONVULSION |
32 |
0.0006 |
| 821 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
13 |
0.0006 |
| 822 |
CHEST DISCOMFORT |
57 |
0.0006 |
| 823 |
SINUS DISORDER |
11 |
0.0006 |
| 824 |
PRODUCT PRESCRIBING ERROR |
13 |
0.0005 |
| 825 |
SKIN DISCOLOURATION |
25 |
0.0005 |
| 826 |
DYSPHAGIA |
51 |
0.0005 |
| 827 |
RIB FRACTURE |
11 |
0.0005 |
| 828 |
THROMBOSIS |
43 |
0.0005 |
| 829 |
PHOTOPHOBIA |
10 |
0.0005 |
| 830 |
RASH |
231 |
0.0005 |
| 831 |
MUSCULOSKELETAL DISORDER |
10 |
0.0005 |
| 832 |
IMPAIRED HEALING |
17 |
0.0005 |
| 833 |
RETCHING |
11 |
0.0005 |
| 834 |
CHEST PAIN |
95 |
0.0005 |
| 835 |
RECTAL HAEMORRHAGE |
22 |
0.0005 |
| 836 |
TREATMENT NONCOMPLIANCE |
28 |
0.0005 |
| 837 |
SOMNOLENCE |
103 |
0.0005 |
| 838 |
BLOOD TRIGLYCERIDES INCREASED |
9 |
0.0005 |
| 839 |
RESPIRATORY ARREST |
14 |
0.0005 |
| 840 |
FAECES DISCOLOURED |
11 |
0.0005 |
| 841 |
MENTAL DISORDER |
22 |
0.0005 |
| 842 |
AGITATION |
37 |
0.0005 |
| 843 |
DIPLOPIA |
13 |
0.0005 |
| 844 |
MALIGNANT NEOPLASM PROGRESSION |
51 |
0.0005 |
| 845 |
ALOPECIA |
97 |
0.0005 |
| 846 |
COGNITIVE DISORDER |
23 |
0.0005 |
| 847 |
RASH PAPULAR |
11 |
0.0005 |
| 848 |
PRODUCT DOSE OMISSION |
32 |
0.0005 |
| 849 |
ANGINA PECTORIS |
14 |
0.0005 |
| 850 |
CONTUSION |
47 |
0.0005 |
| 851 |
OSTEONECROSIS |
16 |
0.0005 |
| 852 |
LOSS OF CONSCIOUSNESS |
62 |
0.0005 |
| 853 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
98 |
0.0005 |
| 854 |
ERYTHEMA |
99 |
0.0005 |
| 855 |
BLISTER |
27 |
0.0005 |
| 856 |
WEIGHT DECREASED |
134 |
0.0005 |
| 857 |
PRODUCT DOSE OMISSION ISSUE |
141 |
0.0005 |
| 858 |
NEOPLASM MALIGNANT |
32 |
0.0005 |
| 859 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
86 |
0.0005 |
| 860 |
BALANCE DISORDER |
41 |
0.0005 |
| 861 |
NIGHT SWEATS |
15 |
0.0005 |
| 862 |
DYSURIA |
17 |
0.0005 |
| 863 |
HEADACHE |
289 |
0.0005 |
| 864 |
MOBILITY DECREASED |
33 |
0.0005 |
| 865 |
DEAFNESS |
12 |
0.0005 |
| 866 |
RASH MACULAR |
16 |
0.0005 |
| 867 |
FEMUR FRACTURE |
14 |
0.0005 |
| 868 |
PSYCHOTIC DISORDER |
13 |
0.0004 |
| 869 |
BONE DISORDER |
8 |
0.0004 |
| 870 |
INCORRECT DOSE ADMINISTERED |
100 |
0.0004 |
| 871 |
INFUSION RELATED REACTION |
29 |
0.0004 |
| 872 |
HERPES ZOSTER |
25 |
0.0004 |
| 873 |
CARDIOVASCULAR DISORDER |
11 |
0.0004 |
| 874 |
FALL |
142 |
0.0004 |
| 875 |
EYE PAIN |
24 |
0.0004 |
| 876 |
DIABETES MELLITUS |
32 |
0.0004 |
| 877 |
DRY MOUTH |
34 |
0.0004 |
| 878 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
9 |
0.0004 |
| 879 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
14 |
0.0004 |
| 880 |
PRODUCT DISPENSING ERROR |
9 |
0.0004 |
| 881 |
HEAD INJURY |
13 |
0.0004 |
| 882 |
URINARY INCONTINENCE |
12 |
0.0004 |
| 883 |
ECZEMA |
21 |
0.0004 |
| 884 |
UNEVALUABLE EVENT |
30 |
0.0004 |
| 885 |
BACK PAIN |
92 |
0.0004 |
| 886 |
DRUG ADMINISTRATION ERROR |
12 |
0.0004 |
| 887 |
INTERNATIONAL NORMALISED RATIO INCREASED |
11 |
0.0004 |
| 888 |
SWELLING FACE |
25 |
0.0004 |
| 889 |
GASTRITIS |
10 |
0.0004 |
| 890 |
VISION BLURRED |
51 |
0.0004 |
| 891 |
OVERDOSE |
80 |
0.0004 |
| 892 |
TINNITUS |
17 |
0.0004 |
| 893 |
MUSCULOSKELETAL STIFFNESS |
32 |
0.0004 |
| 894 |
BRONCHITIS |
27 |
0.0004 |
| 895 |
ABDOMINAL DISCOMFORT |
61 |
0.0004 |
| 896 |
DYSGEUSIA |
27 |
0.0004 |
| 897 |
HAEMATOCHEZIA |
20 |
0.0004 |
| 898 |
VISUAL ACUITY REDUCED |
12 |
0.0004 |
| 899 |
PRODUCT DOSE OMISSION IN ERROR |
10 |
0.0004 |
| 900 |
PAIN IN JAW |
10 |
0.0004 |
| 901 |
SWELLING |
33 |
0.0004 |
| 902 |
HYPOGLYCAEMIA |
17 |
0.0004 |
| 903 |
EYE SWELLING |
13 |
0.0003 |
| 904 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
18 |
0.0003 |
| 905 |
HIP FRACTURE |
11 |
0.0003 |
| 906 |
MEDICATION ERROR |
19 |
0.0003 |
| 907 |
ILLNESS |
35 |
0.0003 |
| 908 |
EYE DISORDER |
11 |
0.0003 |
| 909 |
ADVERSE DRUG REACTION |
30 |
0.0003 |
| 910 |
DISTURBANCE IN ATTENTION |
18 |
0.0003 |
| 911 |
BLOOD PRESSURE FLUCTUATION |
8 |
0.0003 |
| 912 |
THERAPY CESSATION |
17 |
0.0003 |
| 913 |
LACRIMATION INCREASED |
10 |
0.0003 |
| 914 |
DYSPEPSIA |
32 |
0.0003 |
| 915 |
RHINORRHOEA |
21 |
0.0003 |
| 916 |
FEELING COLD |
9 |
0.0003 |
| 917 |
DIZZINESS |
161 |
0.0003 |
| 918 |
CARDIAC DISORDER |
30 |
0.0003 |
| 919 |
BONE DENSITY DECREASED |
10 |
0.0003 |
| 920 |
DYSARTHRIA |
12 |
0.0003 |
| 921 |
GAIT DISTURBANCE |
61 |
0.0003 |
| 922 |
UNDERDOSE |
23 |
0.0003 |
| 923 |
HYPERSOMNIA |
9 |
0.0003 |
| 924 |
OROPHARYNGEAL PAIN |
29 |
0.0003 |
| 925 |
MALAISE |
134 |
0.0003 |
| 926 |
PARAESTHESIA |
48 |
0.0003 |
| 927 |
PRURITUS |
117 |
0.0003 |
| 928 |
WHEEZING |
18 |
0.0003 |
| 929 |
HEART RATE INCREASED |
30 |
0.0003 |
| 930 |
ABDOMINAL PAIN UPPER |
62 |
0.0003 |
| 931 |
ACCIDENTAL OVERDOSE |
11 |
0.0003 |
| 932 |
TRANSIENT ISCHAEMIC ATTACK |
10 |
0.0003 |
| 933 |
ANGIOEDEMA |
13 |
0.0003 |
| 934 |
COLITIS ULCERATIVE |
13 |
0.0003 |
| 935 |
CHRONIC KIDNEY DISEASE |
22 |
0.0003 |
| 936 |
BLOOD PRESSURE DECREASED |
19 |
0.0003 |
| 937 |
DEPRESSED MOOD |
15 |
0.0003 |
| 938 |
NEPHROLITHIASIS |
13 |
0.0003 |
| 939 |
FLATULENCE |
16 |
0.0003 |
| 940 |
WEIGHT INCREASED |
63 |
0.0003 |
| 941 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
20 |
0.0003 |
| 942 |
DRY SKIN |
37 |
0.0003 |
| 943 |
PAIN IN EXTREMITY |
81 |
0.0003 |
| 944 |
DYSPHONIA |
16 |
0.0003 |
| 945 |
JOINT SWELLING |
33 |
0.0003 |
| 946 |
ARTHRALGIA |
113 |
0.0003 |
| 947 |
PAIN |
165 |
0.0003 |
| 948 |
VERTIGO |
16 |
0.0003 |
| 949 |
GASTROOESOPHAGEAL REFLUX DISEASE |
21 |
0.0003 |
| 950 |
HYPOAESTHESIA |
39 |
0.0003 |
| 951 |
INSOMNIA |
69 |
0.0003 |
| 952 |
HYPOACUSIS |
11 |
0.0003 |
| 953 |
MEMORY IMPAIRMENT |
35 |
0.0003 |
| 954 |
DRUG DOSE OMISSION |
42 |
0.0003 |
| 955 |
ANAPHYLACTIC REACTION |
14 |
0.0003 |
| 956 |
ILL-DEFINED DISORDER |
15 |
0.0002 |
| 957 |
POLLAKIURIA |
10 |
0.0002 |
| 958 |
OSTEOARTHRITIS |
10 |
0.0002 |
| 959 |
MYOCARDIAL INFARCTION |
41 |
0.0002 |
| 960 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
11 |
0.0002 |
| 961 |
URTICARIA |
38 |
0.0002 |
| 962 |
THERAPEUTIC RESPONSE UNEXPECTED |
10 |
0.0002 |
| 963 |
BLOOD PRESSURE INCREASED |
34 |
0.0002 |
| 964 |
NASAL CONGESTION |
13 |
0.0002 |
| 965 |
MUSCLE SPASMS |
40 |
0.0002 |
| 966 |
ANXIETY |
62 |
0.0002 |
| 967 |
AMNESIA |
14 |
0.0002 |
| 968 |
NECK PAIN |
12 |
0.0002 |
| 969 |
SLEEP DISORDER |
15 |
0.0002 |
| 970 |
FLUSHING |
21 |
0.0002 |
| 971 |
PALPITATIONS |
24 |
0.0002 |
| 972 |
ACNE |
15 |
0.0002 |
| 973 |
BLOOD GLUCOSE INCREASED |
37 |
0.0002 |
| 974 |
THERAPY INTERRUPTED |
14 |
0.0002 |
| 975 |
BLOOD CHOLESTEROL INCREASED |
9 |
0.0002 |
| 976 |
ARTHRITIS |
15 |
0.0002 |
| 977 |
OCULAR HYPERAEMIA |
9 |
0.0002 |
| 978 |
FEELING ABNORMAL |
44 |
0.0002 |
| 979 |
ASTHMA |
20 |
0.0002 |
| 980 |
NASOPHARYNGITIS |
32 |
0.0002 |
| 981 |
HYPERSENSITIVITY |
32 |
0.0002 |
| 982 |
SPEECH DISORDER |
9 |
0.0002 |
| 983 |
INTENTIONAL PRODUCT MISUSE |
15 |
0.0002 |
| 984 |
IRRITABILITY |
10 |
0.0002 |
| 985 |
SUICIDAL IDEATION |
15 |
0.0002 |
| 986 |
ARTHROPATHY |
9 |
0.0002 |
| 987 |
INFLUENZA LIKE ILLNESS |
13 |
0.0002 |
| 988 |
PRODUCT QUALITY ISSUE |
21 |
0.0002 |
| 989 |
SURGERY |
9 |
0.0002 |
| 990 |
FEELING HOT |
9 |
0.0001 |
| 991 |
CEREBROVASCULAR ACCIDENT |
24 |
0.0001 |
| 992 |
DEPRESSION |
30 |
0.0001 |
| 993 |
HYPERHIDROSIS |
15 |
0.0001 |
| 994 |
MIGRAINE |
11 |
0.0001 |